Related Experiment Videos
[Central serous chorioretinopathy induced by corticosteroids]
E Song1, M Wakakura, S Ishikawa
1Department of Ophthalmology, Kitasato University School of Medicine, Kanagawa-ken, Japan.
Nippon Ganka Gakkai Zasshi
|March 1, 1997
Summary
Systemic corticosteroid treatment can induce central serous chorioretinopathy (CSC). Corticosteroid-induced CSC differs from idiopathic CSC, with distinct patient demographics and latency periods observed.
Area of Science:
- Ophthalmology
- Endocrinology
Background:
- Central serous chorioretinopathy (CSC) is a condition affecting vision.
- Systemic corticosteroid use is a known risk factor for various ocular conditions.
Observation:
- This study investigated 5 new cases of CSC during corticosteroid treatment, alongside 28 prior cases.
- Clinical differences between idiopathic CSC and corticosteroid-induced CSC were examined.
- Nine cases of corticosteroid-induced multifocal posterior pigment epitheliopathy (MPPE) were also reviewed.
Findings:
- Corticosteroid-induced CSC patients were older and less male-dominant compared to idiopathic CSC.
- Two latency groups were identified: short (within 70 days) and prolonged (over 6 months) corticosteroid administration.
- Higher daily prednisolone doses (>20 mg/day) were associated with short latency, while lower doses (<20 mg/day) correlated with prolonged latency.
Implications:
- Understanding these differences aids in diagnosing and managing corticosteroid-induced CSC.
- Identifying specific patient groups and latency patterns can inform clinical practice.
- The potential of immunosuppressive drugs to reduce the required corticosteroid dose warrants further investigation.